Drug Trial Radar · NCT04426968
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Last checked: Nov 19, 2026Latest source record: Jan 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Jun 18, 2021
Primary completion
Nov 1, 2023
Study completion Nov 29, 2023
Sponsor
- Lead sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 11, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase II Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-effect Relationship Study of Hepalatide for Injection Combined with Pegylated Interferon in Subjects with Chronic Hepatitis B
Conditions
- Hepatitis B, Chronic
Interventions
Hepalatide 2.1mgDrug
2.1 mg/day subcutaneously (s.c.) for 24 week
Hepalatide 4.2mgDrug
4.2mg/day subcutaneously (s.c.) for 24 week
Hepalatide 6.3mgDrug
6.3mg/day subcutaneously (s.c.) for 24 week
placebo 2.1mgDrug
2.1 mg/day subcutaneously (s.c.) for 24 week
placebo 4.2mgDrug
4.2 mg/day subcutaneously (s.c.) for 24 week
placebo 6.3mgDrug
6.3 mg/day subcutaneously (s.c.) for 24 week
Pegylated InterferonDrug
180 ug/week subcutaneously (s.c.) for 28 week
Primary outcomes
What the sponsor says the trial is designed to measure.
- virological responseTime frame: 24weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Jilin Hepatobiliary Disease Hospital
Changchun, China
The first hospital of Jilin University
Changchun, China
Chizhou People's Hospital
Chizhou, China
The First Hospital Affiliated to the Army Medical University
Chongqing, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
The Second Hospital of Nanjing
Nanjing, China
Qingyuan People's Hospital
Qingyuan, China
Shanghai Tongren Hospital
Shanghai, China
The Sixth People's Hospital of Shenyang
Shenyang, China
Henan Provincial People's Hospital
Zhengzhou, China
Henan Provincial Infectious Disease Hospital
Zhenzhou, China
The fifth medical center of PLA
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.